These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3825715)

  • 1. Dementia of Parkinson's disease.
    Korczyn AD; Inzelberg R; Treves T; Neufeld M; Reider I; Rabey PM
    Adv Neurol; 1987; 45():399-403. PubMed ID: 3825715
    [No Abstract]   [Full Text] [Related]  

  • 2. Case 2, 1994: parkinsonism and cognitive impairment.
    Gordon MF; Weiner WJ; Koller WC; Rao TH; Chehebar V; Dickson DW
    Mov Disord; 1994 Nov; 9(6):679-86. PubMed ID: 7845411
    [No Abstract]   [Full Text] [Related]  

  • 3. Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia.
    Xuereb JH; Tomlinson BE; Irving D; Perry RH; Blessed G; Perry EK
    Adv Neurol; 1990; 53():35-40. PubMed ID: 2173374
    [No Abstract]   [Full Text] [Related]  

  • 4. What is it? Case 1, 1994: rapidly progressive aphasia, apraxia, dementia, myoclonus, and parkinsonism.
    Wojcieszek J; Lang AE; Jankovic J; Greene P; Deck J
    Mov Disord; 1994 May; 9(3):358-66. PubMed ID: 7518892
    [No Abstract]   [Full Text] [Related]  

  • 5. Dementia in Parkinson's disease. Morphometric data.
    Duyckaerts C; Gaspar P; Costa C; Bonnet AM; Hauw JJ
    Adv Neurol; 1993; 60():447-55. PubMed ID: 8420169
    [No Abstract]   [Full Text] [Related]  

  • 6. Is "subcortical dementia" a recognizable clinical entity?
    Mayeux R; Stern Y; Rosen J; Benson F
    Ann Neurol; 1983 Sep; 14(3):278-83. PubMed ID: 6227275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia in Parkinson's disease and (pre) senile dementia of Alzheimer type: morphological aspects and changes in the intracerebral MAO activity.
    Jellinger K; Riederer P
    Adv Neurol; 1984; 40():199-210. PubMed ID: 6695595
    [No Abstract]   [Full Text] [Related]  

  • 8. Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins.
    Vermersch P; Delacourte A; Javoy-Agid F; Hauw JJ; Agid Y
    Ann Neurol; 1993 May; 33(5):445-50. PubMed ID: 8498822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parkinson's disease and Alzheimer's disease--similarities in magnetic resonance imaging parameters and their possible explanation].
    Ebmeier KP; Besson JA; Cherryman G; Smith F
    Z Gerontol; 1988; 21(3):142-5. PubMed ID: 3407284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of amyloid-beta deposition in the cerebral cortex in Parkinson's disease.
    Mastaglia FL; Johnsen RD; Byrnes ML; Kakulas BA
    Mov Disord; 2003 Jan; 18(1):81-6. PubMed ID: 12518303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of morphological changes in Parkinson's disease.
    Jellinger K
    Adv Neurol; 1987; 45():1-18. PubMed ID: 3825687
    [No Abstract]   [Full Text] [Related]  

  • 12. Dementia--an update.
    Jagust W
    West J Med; 1995 Nov; 163(5):473-4. PubMed ID: 8533415
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical features of Parkinson's disease in 100 histologically proven cases.
    Hughes AJ; Daniel SE; Lees AJ
    Adv Neurol; 1993; 60():595-9. PubMed ID: 8420197
    [No Abstract]   [Full Text] [Related]  

  • 14. Amyloid beta-peptide and the dementia of Parkinson's disease.
    Jendroska K; Lees AJ; Poewe W; Daniel SE
    Mov Disord; 1996 Nov; 11(6):647-53. PubMed ID: 8914090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly.
    Kuzuhara S; Yoshimura M
    Adv Neurol; 1993; 60():464-9. PubMed ID: 8420171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
    Liberini P
    Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Brenner SR
    Neurology; 2008 Jun; 70(23):2265; author reply 2265. PubMed ID: 18519878
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis of dementia syndromes.
    Geldmacher DS
    Clin Geriatr Med; 2004 Feb; 20(1):27-43. PubMed ID: 15062485
    [No Abstract]   [Full Text] [Related]  

  • 20. Cognitive impairments in Parkinson's disease.
    Growdon JH; Corkin S
    Adv Neurol; 1987; 45():383-92. PubMed ID: 2881447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.